At a Glance
Dosage
oral
| Level | 1B-LSD | 1cP-MiPLA |
|---|---|---|
| Threshold | 15 µg | 50 µg |
| Light | 25–75 µg | 100–150 µg |
| Common | 75–150 µg | 150–200 µg |
| Strong | 150–300 µg | 200–250 µg |
| Heavy | 300 µg | 300 µg |
Duration
oral
1B-LSD
oral
Total: 8 hrs – 12 hrsPeak
Offset
Afterglow
Onset20 min – 1 hrs
Come Up45 min – 2 hrs
Peak3 hrs – 5 hrs
Offset
Effects
Safety
Interaction: 1B-LSD + 1cP-MiPLA
No direct interaction data available between these substances. This does not mean the combination is safe.
1B-LSD — Dangerous Interactions
No dangerous interactions recorded.
1cP-MiPLA — Dangerous Interactions
No dangerous interactions recorded.
Frequently Asked Questions
What is the difference between 1B-LSD and 1cP-MiPLA?
1B-LSD is classified as a Psychedelic (Lysergamides) while 1cP-MiPLA is classified as a Psychedelic (Lysergamides). They share 64 effects in common, with 15 effects unique to 1B-LSD and 6 unique to 1cP-MiPLA.
Is it safe to combine 1B-LSD and 1cP-MiPLA?
There is no direct interaction data available for combining 1B-LSD and 1cP-MiPLA. This does not mean the combination is safe. Always exercise caution and research thoroughly.
Which is stronger, 1B-LSD or 1cP-MiPLA?
At common doses via oral, 1B-LSD is typically dosed at 75–150 µg while 1cP-MiPLA is dosed at 150–200 µg. However, "stronger" depends on context — potency, subjective intensity, and duration all factor in. These substances have different pharmacological profiles and comparing raw potency is not straightforward.